1. Home
  2. NEON vs OTLK Comparison

NEON vs OTLK Comparison

Compare NEON & OTLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neonode Inc.

NEON

Neonode Inc.

HOLD

Current Price

$1.80

Market Cap

27.5M

Sector

Technology

ML Signal

HOLD

Logo Outlook Therapeutics Inc.

OTLK

Outlook Therapeutics Inc.

HOLD

Current Price

$0.31

Market Cap

29.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEON
OTLK
Founded
1997
2010
Country
Sweden
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.5M
29.2M
IPO Year
1994
2016

Fundamental Metrics

Financial Performance
Metric
NEON
OTLK
Price
$1.80
$0.31
Analyst Decision
Hold
Buy
Analyst Count
1
4
Target Price
$6.00
$2.50
AVG Volume (30 Days)
96.9K
4.2M
Earning Date
05-13-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
37.88
55.91
EPS
N/A
N/A
Revenue
$3,108,000.00
$8,146,123.00
Revenue This Year
$72.74
$1,430.98
Revenue Next Year
$28.94
$173.23
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.27
$0.16
52 Week High
$29.90
$3.39

Technical Indicators

Market Signals
Indicator
NEON
OTLK
Relative Strength Index (RSI) 57.55 59.76
Support Level $1.66 $0.17
Resistance Level $1.91 $0.39
Average True Range (ATR) 0.11 0.03
MACD 0.00 0.01
Stochastic Oscillator 67.14 65.24

Price Performance

Historical Comparison
NEON
OTLK

About NEON Neonode Inc.

Neonode Inc provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. Its machine perception solutions are based on the MultiSensing technology platform. The company also offers optical sensing solutions for contactless touch and gesture sensing. It markets and sells its solutions mainly to customers in the automotive sector, along with other markets such as office equipment, industrial automation, medical, military, and avionics. Geographically, the company operates in Japan, South Korea, Germany, Sweden, China, and other regions, with a majority of its revenue generated from Japan.

About OTLK Outlook Therapeutics Inc.

Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA, which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.

Share on Social Networks: